biotech · Parkinson Disease · Amyotrophic Lateral Sclerosis · DNLI
Denali Therapeutics
NovaPharmaNews editorial coverage mentioning Denali Therapeutics — regulatory, clinical, and market analysis.
161 Oyster Point Blvd, South San Francisco, California 94080, US HQ
2015 Founded
567 Employees
Public company Type
DNLI · NYSE Ticker
Company details
- Status
- Public
- HQ
- 161 Oyster Point Blvd, South San Francisco, California 94080, US
- Founded
- 2015
- Employees
- 567
- Programs
- 23
- Drugs
- 10
- Patents
- 42
News & analysis
NovaPharmaNews articles mentioning Denali Therapeutics — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Denali Therapeutics — regulatory, clinical, and market analysis.